Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Lou, Q. Ye, H. Dai, K. Huang, C. Wang (Beijing, China). LATE-BREAKING ABSTRACT: Aggravation of bleomycin-induced pulmonary fibrosis in senescence-accelerated mouse. Eur Respir J 2012; 40: Suppl. 56, 3671

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Amelioration of hyperoxia-induced lung injury in newborn mice using a sphingolipid-based intervention Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012 Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Rikkunshito ameliorates bleomycin-induced lung injury in mice Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 The effect of interferon-γ on bleomycin-induced alveolitis and pulmonary fibrosis in rats Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 Effect of fasudil on the bleomycin-induced pulmonary fibrosis and hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 Ghrelin protects against bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Chronic intermittent hypoxia exacerbates lung fibrosis in bleomycin-induced lung injury mouse model Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018 17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Amelioration of bleomycin-induced pneumopathy in mice by interleukin-4 Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 Effects of drotrecogin-alpha on the bleomycin-induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 Expression of TGF-β and TGFβ receptors in bleomycin-induced pulmonary fibrosis of rats Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002 The effect of pravastatin on bleomycin-induced lung injury and fibrosis in mouse Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010 HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Leukotriene (LT)C4 aggravate bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Leukotriene (LT)C4 aggravate bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Late Breaking Abstract - PRRX1 inhibition decreases fibrosis in the bleomycin-induced lung fibrosis model in mice Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 The novel oligonucleotide therapeutics PK-7010 for TGF-ß1 ameliorates bleomycin-induced pulmonary fibrosis in mice Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 LATE-BREAKING ABSTRACT: BRP-39 contribute to cigarette smoke-induced inflammation and emphysema in mice and humans Source: Annual Congress 2009 - Airway cell biology Year: 2009 Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006